Goldman Sachs cuts Eastman Chemical stock price target on margin pressures
Goldman Sachs reduced its price target for Eastman Chemical (NYSE:EMN) to $72 from $73, citing Q3 earnings misses and margin pressures. The company reported adjusted EPS of $1.84 and adjusted EBIT of $305 million, both below expectations. Eastman Chemical also lowered its full-year 2026 adjusted EPS guidance to $6.00-$6.20, below consensus. The stock trades at $66.53, with a P/E ratio of 17.27 and a market cap of $7.61 billion.
How this was made
The 30-second read
Why it matters
The downgrade reinforces negative sentiment and may accelerate a sell‑off, but the DOE grant and 2027 guidance could provide a floor.
Market read
The article provides fresh earnings and analyst coverage data that can affect EMN's short‑term price action.
What to watch
Potential upside from the DOE grant and upcoming 2027 fiber earnings recovery.
Background
Eastman Chemical reported Q3 2026 results that fell short of expectations, prompting Goldman Sachs to cut its price target.
Ticker impact
Goldman Sachs lowered its price target on Eastman Chemical after the company reported a Q3 earnings miss and weaker guidance.
likely downward pressure as the market prices in the lower target and earnings miss
Analyst downgrade combined with missed earnings and guidance typically leads to near‑term price declines.
Market effects
Chemicals sector may face broader scrutiny as price‑cost pressures affect peers.
U.S. market participants may adjust exposure to specialty chemicals.
Limited to investors tracking industrial and specialty chemical stocks.
Counterpoint
If the earnings miss is viewed as a temporary setback, the stock could be undervalued after the downgrade.
Key entities
- AnalystGoldman Sachs
Reduced EMN price target to $72 from $73.
- CompanyEastman Chemical
Reported Q3 earnings miss and lowered full‑year guidance.



